BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Oxford Immunotec Limited (OXFD) Announces Closing Of Initial Public Offering And Exercise Of Over-Allotment Option


12/2/2013 11:14:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Oxford, UK and Marlborough, MA, December 02, 2013 – Oxford Immunotec Global PLC (NASDAQ: OXFD) today announced the closing of its initial public offering of 6,164,000 ordinary shares at an initial public offering price of $12.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 804,000 additional ordinary shares. Oxford estimates net proceeds from the offering to be approximately $62.8 million after deducting underwriting discounts and commissions and estimated offering expenses. The ordinary shares are listed on The NASDAQ Global Market under the trading symbol "OXFD."

J.P. Morgan Securities LLC and Piper Jaffray & Co. acted as joint book-running managers for the offering. Cowen and Company, LLC and Robert W. Baird & Co. Incorporated acted as co-managers.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on November 21, 2013. The offering was made only by means of the written prospectus, copies of which may be obtained by contacting: J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by telephone at (866) 803-9204, or from Piper Jaffray & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, Minnesota 55402 or by telephone at (800) 747-3924, or by e-mailing a request to prospectus@pjc.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Oxford Immunotec Global PLC

Oxford Immunotec Global PLC is a global, commercial-stage diagnostics company committed to improving patient care by providing advanced, innovative tests in the field of immunology. Its proprietary T-SPOT technology platform allows it to measure the responses of specific immune cells, known as T cells, to inform the diagnosis, prognosis and monitoring of patients with immunologically controlled diseases. T cells are a central component of the human body’s immune system, and are implicated in the control and progression of many medical conditions, including certain types of infectious diseases, cancers and autoimmune diseases. Oxford Immunotec Global PLC is headquartered near Oxford, UK and in Marlborough, MA.

Website: www.oxfordimmunotec.com

Media Relations

Beth Elkins

Oxford Immunotec Global PLC

+44 1235 442780

belkins@oxfordimmunotec.com

Investor Relations

Richard M. Altieri

Oxford Immunotec Global PLC

Chief Financial Officer

+1 508-481-4648

raltieri@oxfordimmunotec.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES